Your product is finally on the hospital formulary. You worked hard to secure its approval or you inherited a product that was already on formulary. In either case, you're in an enviable situation.
Your product is finally on the hospital formulary. You worked hard to secure its approval or you inherited a product that was already on formulary. In either case, you're in an enviable situation.
But don't get too comfortable. Just because your product is on the formulary today doesn't mean that it will be there indefinitely. All health care organizations are under great pressure to reduce drug costs, and one way they do that is by putting fewer drugs on their formulary.
So congratulations! Your product is on formulary. Now your real work can begin.
Talk to your manager about developing a strategic plan for your products. Answer these questions: Where do I want to be in sales with these products? What growth expectations does my company have for my products? How am I going to meet these expectations and achieve my goals?
The actual plan needs to be very well thought out and in-line with the objectives of the company. You need to analyze the situation and the market.
Think of the overall market as segmented. Within the hospital, there are segmented markets such as clinics, wards, pharmacies, labs and purchasing agents. Look at all the segments as separate business entities and opportunities operating under the same roof. If you don't think this way already, train yourself to think this way.
The ward is one of the most important areas for your product. Do you know who all the key players are on the ward? Who is the director of the unit? Who is the chief resident? Who are the other residents? How are the products ordered on the ward? Do you know the nursing staff?
Nurses may recommend a product to the doctor if a patient is having pain at night and needs an analgesic. Or, if a patient awakens with a fever, the nurse will call the doctor and ask for his or her permission to give a specific product, such as an antibiotic. Do you know if that product is yours? Spend time with the nursing staff and brief them on your product. Secure their support.
Get back in the ward and keep in contact with the director if and when possible. The chief resident and his or her staff are also key players. Keep them posted on all new information and maintain constant contact.
The microbiology laboratory is very important if you are selling antibiotics. Do they have the right disks, and are they in ample supply? What information about prescribing doctors can they provide?
And what about our friend and ally, the pharmacist? When was the last time you saw him or her to service his or her account? By service, I mean handling a problem, providing information and checking on stock.
Finally, the purchasing agent is an increasingly important person in our selling efforts. These are cost-conscious business professionals who can be very strong supporters. Don't forget them and don't forget that they are very interested in price.
Partnering with territory reps who call on attending physicians at your hospital is another part of your plan. Many times you can get their doctors to influence your hospital-based doctors.
Let your peers know which of your products are on formulary and at what hospitals. Team up with the reps in your territory at least once a month. Meet for lunch and trade information.
Most importantly, never forget that your service and problem-solving follow-through will be what influences the movement of your products and the security of your product on formulary. PR
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Bristol Myers Squibb’s Cobenfy Falls Short in Phase III Trial as Add On Therapy for Schizophrenia
April 23rd 2025In the Phase III ARISE trial, Cobenfy administered as an adjunctive treatment to atypical antipsychotics for patients with inadequately controlled schizophrenia did not achieve statistically significant improvements.